Leigh Baldwin & CO. LLC Makes New Investment in CVS Health Corporation $CVS

Leigh Baldwin & CO. LLC purchased a new stake in CVS Health Corporation (NYSE:CVS) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 8,022 shares of the pharmacy operator’s stock, valued at approximately $830,000.

Several other hedge funds and other institutional investors also recently modified their holdings of the business. Caitong International Asset Management Co. Ltd raised its stake in CVS Health by 407.2% in the third quarter. Caitong International Asset Management Co. Ltd now owns 350 shares of the pharmacy operator’s stock valued at $26,000 after purchasing an additional 281 shares in the last quarter. Swiss RE Ltd. purchased a new position in CVS Health in the 4th quarter worth approximately $26,000. Kilter Group LLC purchased a new position in CVS Health in the 2nd quarter worth approximately $27,000. Sankala Group LLC bought a new position in shares of CVS Health in the 4th quarter worth $28,000. Finally, Global Trust Asset Management LLC raised its position in shares of CVS Health by 344.8% during the 1st quarter. Global Trust Asset Management LLC now owns 387 shares of the pharmacy operator’s stock valued at $28,000 after buying an additional 300 shares in the last quarter. Hedge funds and other institutional investors own 80.66% of the company’s stock.

CVS Health Stock Down 0.0%

NYSE CVS opened at $93.01 on Monday. CVS Health Corporation has a 1 year low of $69.51 and a 1 year high of $110.68. The stock has a market capitalization of $118.96 billion, a PE ratio of 24.61, a PEG ratio of 0.85 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.87 and a quick ratio of 0.66. The business’s 50-day moving average is $102.02 and its 200 day moving average is $88.95.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 EPS for the quarter, beating analysts’ consensus estimates of $1.87 by $0.71. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.The business had revenue of $106.10 billion during the quarter, compared to analyst estimates of $100.03 billion. During the same quarter in the prior year, the company posted $1.81 EPS. CVS Health’s quarterly revenue was up 7.3% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Sell-side analysts forecast that CVS Health Corporation will post 8.02 earnings per share for the current year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, August 3rd. Investors of record on Thursday, July 23rd were paid a $0.665 dividend. The ex-dividend date of this dividend was Thursday, July 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 2.9%. CVS Health’s dividend payout ratio (DPR) is presently 70.37%.

Analyst Upgrades and Downgrades

CVS has been the subject of a number of research analyst reports. Mizuho lifted their price objective on shares of CVS Health from $110.00 to $115.00 and gave the stock an “outperform” rating in a report on Monday, June 8th. Piper Sandler reissued an “overweight” rating and issued a $113.00 target price on shares of CVS Health in a research note on Monday, June 1st. Wall Street Zen raised CVS Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday, August 8th. HSBC restated a “hold” rating and issued a $103.00 target price on shares of CVS Health in a research report on Monday, July 6th. Finally, Truist Financial upped their target price on CVS Health from $108.00 to $118.00 and gave the stock a “buy” rating in a research note on Tuesday, July 14th. Twenty-two investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $107.17.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.